Yield10 Bioscience, Inc. (YTEN)
OTCMKTS
· Delayed Price · Currency is USD
0.870
+0.120 (16.00%)
Oct 25, 2024, 4:00 PM EDT
Yield10 Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -12.7 | -14.46 | -13.57 | -11.03 | -10.21 | -12.96 | Upgrade
|
| Depreciation & Amortization | 0.27 | 0.29 | 0.26 | 0.22 | 0.18 | 0.2 | Upgrade
|
| Other Amortization | - | - | - | - | - | 13.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | - | 0.21 | - | Upgrade
|
| Stock-Based Compensation | 1.58 | 1.7 | 2.04 | 1.79 | 0.85 | 0.75 | Upgrade
|
| Other Operating Activities | 0.45 | 0.31 | 0.56 | 0.39 | 1.11 | -8.17 | Upgrade
|
| Change in Accounts Receivable | - | 0.03 | 0.17 | -0.09 | -0.02 | 0.07 | Upgrade
|
| Change in Accounts Payable | 1.92 | 1.09 | 0.03 | 0.02 | -0.22 | 0.16 | Upgrade
|
| Change in Unearned Revenue | 2.25 | - | - | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 0.43 | 0.97 | -0.89 | -0.56 | -0.56 | -1.73 | Upgrade
|
| Operating Cash Flow | -5.8 | -10.07 | -11.4 | -9.25 | -8.66 | -8.65 | Upgrade
|
| Capital Expenditures | -0.02 | -0.05 | -0.15 | -0.19 | -0.08 | -0.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.01 | - | Upgrade
|
| Investment in Securities | - | 1.99 | 8.68 | -4.39 | -0.58 | -2.95 | Upgrade
|
| Investing Cash Flow | -0.02 | 1.95 | 8.52 | -4.58 | -0.65 | -3.02 | Upgrade
|
| Short-Term Debt Issued | - | 0.97 | - | - | 0.33 | - | Upgrade
|
| Total Debt Issued | -0.03 | 0.97 | - | - | 0.33 | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.03 | 0.97 | - | - | 0.33 | - | Upgrade
|
| Issuance of Common Stock | 4.3 | 5.95 | - | 15.85 | 6.96 | 14.08 | Upgrade
|
| Repurchase of Common Stock | - | -0.04 | -0.04 | -0.1 | -0.02 | -0 | Upgrade
|
| Other Financing Activities | -0.29 | - | - | - | - | - | Upgrade
|
| Financing Cash Flow | 3.98 | 6.87 | -0.04 | 15.75 | 7.28 | 14.08 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.01 | -0.04 | -0.05 | -0.01 | -0.04 | -0.02 | Upgrade
|
| Net Cash Flow | -1.86 | -1.29 | -2.97 | 1.91 | -2.06 | 2.39 | Upgrade
|
| Free Cash Flow | -5.82 | -10.11 | -11.56 | -9.44 | -8.74 | -8.72 | Upgrade
|
| Free Cash Flow Margin | -775.73% | -16856.67% | -2568.44% | -1537.79% | -1093.24% | -1081.27% | Upgrade
|
| Free Cash Flow Per Share | -11.42 | -30.55 | -56.44 | -47.89 | -88.33 | -573.09 | Upgrade
|
| Cash Interest Paid | 0.07 | 0.07 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Levered Free Cash Flow | -1.69 | -4.57 | -6.48 | -5.62 | -5.28 | 9.39 | Upgrade
|
| Unlevered Free Cash Flow | -1.67 | -4.55 | -6.48 | -5.62 | -5.28 | 9.39 | Upgrade
|
| Change in Net Working Capital | -4.37 | -2.52 | 0.22 | 0.13 | 0.32 | -0.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.